T

TRIUMF

Canada’s particle accelerator research facility

Assistant Procurement Specialist

Full-TimeUpdated on 10/24/2026Deadline 11/15/26
CA$59.9k/yr
Junior
Bachelor's
Vancouver, BC, Canada
In Person
Operations & LogisticsProcurement & Sourcing

About the job

Requirements
  • Strong working knowledge of Microsoft Office, including Excel and Word.
  • Good numerical reasoning and aptitude for figures, accuracy, and attention to detail.
  • Ability to multitask and handle multiple priorities.
  • Thorough knowledge of centralized purchasing principles and practices, national standards of purchasing methods, and the full supply chain process.
  • Solid understanding of common procurement practices, including supplier quotes, payment terms, and shipment methods.
  • Bachelor’s degree in Supply Chain Management or a related field, and at least one year of post-graduation experience in a procurement environment.
  • A designation such as SCMP (Supply Chain Management Professional) by Supply Chain Canada, CSCP (Certified Supply Chain Professional) through APICS/ASCM or equivalent, or working toward certification.
Responsibilities
  • Process requisitions and issue purchase orders, make return requests with suppliers, maintain an up-to-date supplier database, participate in supplier onboarding as necessary, and prepare reports as requested.
  • Track purchase orders, handle inquiries about the orders, and manage the purchase-order lifecycle.
  • Respond to questions from customs brokers and vendors.
  • Communicate with vendor representatives to establish best pricing.
  • Review and process change orders.
  • Provide customer service to internal and external stakeholders, including team members in Finance and Supply Chain.
  • Follow the Supply Chain Policy and Procedures.
Desired Qualifications
  • ERP experience, such as Workday.

About the company

TRIUMF is Canada’s national particle accelerator centre in Vancouver, running a large accelerator complex for research in particle and nuclear physics. Researchers use its facilities to study fundamental matter and to develop practical technologies, including medical isotopes and materials science applications. It differentiates itself through nationwide university collaborations, a multidisciplinary team, and a direct path from basic discoveries to real-world benefits. Its goal is to advance science while building Canadian leadership in science and technology and training the next generation of scientists, engineers, and leaders.

Company Size

501-1,000

Company Stage

Grant

Total Funding

$293.2M

Headquarters

Vancouver, Canada

Founded

1968

Get referred to TRIUMF

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • BC’s $32 million cancer investment expands PET/CT capacity from 16,000 to 41,000 scans.
  • TRIUMF’s July 2026 benchmark strengthens grant leverage for advanced neutron and antimatter programs.
  • The 2025 CERN statement and 2026 summer-student pipeline reinforce TRIUMF’s talent and partnership moat.

What critics are saying

  • TRIUMF depends on public funding; the 2024 federal package and 2025 ministerial support dominate budgets.
  • Health Canada licensing and 2026 commissioning for the cyclotron can delay cancer-research revenue.
  • A failed nEDM or isotope program would weaken TRIUMF’s scientific relevance and funding case.

What makes TRIUMF unique

  • TRIUMF’s 2026 ultracold neutron source leads the world with 6.7×10⁵ neutrons per second.
  • Canada’s CERN partnership and TRIUMF-ATLAS work keep TRIUMF embedded in global physics networks.
  • TRIUMF’s UBC campus location anchors isotope science beside BC Cancer and Health Canada licensing.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Wellness Program
  • Parental Leave
  • Paid Vacation

Growth & Insights and Company News

6 month growth

13%

1 year growth

13%

2 year growth

13%
SNOLAB
May 21st, 2025
Former SNOLAB director elected Fellow of the Royal Society

Smith left SNOLAB in 2021 to take on the role of executive director and CEO of TRIUMF in Vancouver.

Government of British Columbia
Jan 30th, 2024
BC Gov News

The Province is investing $32 million to support this work through $21 million to BC Cancer for the new cyclotron and radiopharmacy laboratory and approximately $11 million to TRIUMF to advance research.